TGFB1 and breast carcinoma: Taken together, these results suggest a positive feedback loop mechanism by which TGFβ/Smad signaling represses expression of its own inhibitory molecule, BCAR3, further leading to enhanced TGFβ/Smad signaling in breast cancer cells (Figure 8g).